ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
LAPATAX: A randomized phase II trial of FEC-docetaxel combined with lapatinib and/or trastuzumab as neoadjuvant therapy of HER2-positive breast cancer—EORTC 10054 trial.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.tps116
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. TPS116-TPS116
◽
Cited By ~ 2
Author(s):
D. A. Cameron
◽
S. Marreaud
◽
K. Zaman
◽
A. Bodmer
◽
J. Pierga
◽
...
Keyword(s):
Breast Cancer
◽
Neoadjuvant Therapy
◽
Phase Ii
◽
Phase Ii Trial
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Randomized Phase Ii
◽
Positive Breast Cancer
Download Full-text
Related Documents
Cited By
References
Interim Results of BACH: Randomized Phase II Trial Evaluating the Safety of Two Chemotherapy Regimens as Adjuvant Therapy in Patients with HER2-Positive Breast Cancer: PLD + Cyclophosphamide + Trastuzumab (PLD+C+H), or Doxorubicin + Cyclophosphomide (A+C), Each Followed by Paclitaxel + Trastuzumab (T+H).
10.1158/0008-5472.sabcs-09-2085
◽
2009
◽
Cited By ~ 2
Author(s):
D. Rayson
◽
T. Suter
◽
S. van der Vegt
◽
C. Jackisch
◽
A. Lluch
◽
...
Keyword(s):
Breast Cancer
◽
Adjuvant Therapy
◽
Phase Ii
◽
Phase Ii Trial
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Randomized Phase Ii
◽
Positive Breast Cancer
Download Full-text
Abstract P5-19-07: Randomized Phase II trial of afatinib alone or with vinorelbine versus investigator's choice of treatment in patients with HER2-positive breast cancer with progressive brain metastases after trastuzumab and/or lapatinib-based therapy: LUX-Breast 3
10.1158/1538-7445.sabcs14-p5-19-07
◽
2015
◽
Cited By ~ 2
Author(s):
Javier Cortés
◽
Veronique Dieras
◽
Jungsil Ro
◽
Jérôme Barriere
◽
Thomas Bachelot
◽
...
Keyword(s):
Breast Cancer
◽
Brain Metastases
◽
Phase Ii
◽
Phase Ii Trial
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Randomized Phase Ii
◽
Choice Of Treatment
◽
Positive Breast Cancer
Download Full-text
5149 Randomized phase II trial of preoperative chemotherapy plus lapatinib, trastuzumab or both in HER2 positive breast cancer: results of the first step simon's design
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(09)71041-9
◽
2009
◽
Vol 7
(2)
◽
pp. 304
Author(s):
V. Guarneri
◽
A. Frassoldati
◽
A. Bottini
◽
K. Cagossi
◽
L. Cavanna
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Preoperative Chemotherapy
◽
Phase Ii Trial
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Randomized Phase Ii
◽
Positive Breast Cancer
Download Full-text
Ki-67 Index Guided Selection of Preoperative Chemotherapy for HER2-positive Breast Cancer: A Randomized Phase II Trial
Japanese Journal of Clinical Oncology
◽
10.1093/jjco/hys161
◽
2012
◽
Vol 42
(12)
◽
pp. 1211-1214
◽
Cited By ~ 7
Author(s):
T. Yamaguchi
◽
H. Mukai
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Preoperative Chemotherapy
◽
Phase Ii Trial
◽
Her2 Positive
◽
Ki 67
◽
Her2 Positive Breast Cancer
◽
Randomized Phase Ii
◽
Selection Of
◽
Positive Breast Cancer
Download Full-text
Abstract OT1-1-15: LUX-Breast 3: Randomized Phase II trial of afatinib (BIBW 2992) alone or with vinorelbine versus investigator's choice of treatment in patients (pts) with HER2-positive breast cancer (BC) with progressive brain metastases after trastuzumab and/or lapatinib-based therapy*
10.1158/0008-5472.sabcs12-ot1-1-15
◽
2012
◽
Cited By ~ 1
Author(s):
H Joensuu
◽
M Ould-Kaci
Keyword(s):
Breast Cancer
◽
Brain Metastases
◽
Phase Ii
◽
Phase Ii Trial
◽
Her2 Positive
◽
Bibw 2992
◽
Her2 Positive Breast Cancer
◽
Randomized Phase Ii
◽
Choice Of Treatment
◽
Positive Breast Cancer
Download Full-text
Randomized phase II trial of preoperative lapatinib versus placebo in HER2-positive breast cancer.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.576
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. 576-576
◽
Cited By ~ 2
Author(s):
A. De Censi
◽
M. Puntoni
◽
G. Pruneri
◽
A. Guerrieri-Gonzaga
◽
M. Cazzaniga
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Randomized Phase Ii
◽
Positive Breast Cancer
Download Full-text
Safety and Activity Report of a Randomized Phase II Trial of Preoperative Anthracycline-Based Chemotherapy Plus Lapatinib, Trastuzumab or Both in HER2 Positive Breast Cancer: CHERLOB Trial.
10.1158/0008-5472.sabcs-09-1093
◽
2009
◽
Cited By ~ 4
Author(s):
V. Guarneri
◽
A. Frassoldati
◽
A. Bottini
◽
K. Cagossi
◽
F. Piacentini
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Randomized Phase Ii
◽
Activity Report
◽
Positive Breast Cancer
Download Full-text
Abstract PS13-14: A randomized, opened, phase II trial assessing the efficacy and safety of ATH-TH(doxorubicin/docetaxel/trastuzumab followed by docetaxel/trastuzumab) versus TCH(docetaxel/carboplatin/trastuzumab) as neoadjuvant treatment in HER2-positive breast cancer
10.1158/1538-7445.sabcs20-ps13-14
◽
2021
◽
Author(s):
Tao Wang
◽
Jin-Mei Zhou
◽
Xiao-Peng Hao
◽
Hui-Qaing Zhang
◽
Shao-Hua Zhang
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Neoadjuvant Treatment
◽
Efficacy And Safety
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Abstract P1-08-36: Neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER). Analysis of biomarkers
10.1158/0008-5472.sabcs13-p1-08-36
◽
2013
◽
Author(s):
M Fernández
◽
N Martinez
◽
I Calvo
◽
E Garcia
◽
L Ugidos
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Neoadjuvant Treatment
◽
Weekly Paclitaxel
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
A randomized, two-arm, phase II trial assessing the efficacy and safety of anthracycline or carboplatin plus docetaxel and tratuzumab as neoadjuvant treatment in HER2-positive breast cancer and prognosis of CTC
The Breast
◽
10.1016/s0960-9776(17)30271-0
◽
2017
◽
Vol 32
◽
pp. S83
Author(s):
T. Wang
◽
J. Zhou
◽
S. Zhang
◽
J. Xiao
◽
H. Zhang
◽
...
Keyword(s):
Breast Cancer
◽
Phase Ii
◽
Phase Ii Trial
◽
Neoadjuvant Treatment
◽
Efficacy And Safety
◽
Her2 Positive
◽
Her2 Positive Breast Cancer
◽
Positive Breast Cancer
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close